Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Treatment of toxic epidermal necrolysis/Stevens-Johnson’s Syndrome with topical steroid to characterize the genetic makeup of the disease.
a study on Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Clobetasol Clobetasol 0.05% ointment
Lead Scientist at UC Davis
- Emanual Maverakis, MD
Associate Professor, Dermatology. Authored (or co-authored) 131 research publications.